Long-term heart transplant outcomes after lowering fixed pulmonary hypertension using left ventricular assist devices† | Zendy

R. Moayedifar | Zendy; Andreas Zuckermann | Zendy; A. Aliabadi-Zuckermann | Zendy; Julia Riebandt | Zendy; Philipp Angleitner | Zendy; Kamen Dimitrov | Zendy; T. Schloeglhofer | Zendy; Angela Rajek | Zendy; Günther Laufer | Zendy; Daniel Zimpfer | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Long-term heart transplant outcomes after lowering fixed pulmonary hypertension using left ventricular assist devices†

Author(s) -

R. Moayedifar,

Andreas Zuckermann,

A. Aliabadi-Zuckermann,

Julia Riebandt,

Philipp Angleitner,

Kamen Dimitrov,

T. Schloeglhofer,

Angela Rajek,

Günther Laufer,

Daniel Zimpfer

Publication year - 2018

Publication title -

european journal of cardio-thoracic surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.303

H-Index - 133

eISSN - 1873-734X

pISSN - 1010-7940

DOI - 10.1093/ejcts/ezy214

Subject(s) - medicine , heart failure , ventricular assist device , heart transplantation , destination therapy , cardiology , contraindication , interquartile range , pulmonary hypertension , transplantation , vascular resistance , surgery , hemodynamics , alternative medicine , pathology

Fixed pulmonary hypertension (fPH) is a contraindication for heart transplantation (HTX). Left ventricular assist device (LVAD) implantation as a bridge to candidacy can reverse fPH in patients with terminal heart failure by chronic left ventricular unloading. We report our institutional experience with terminal heart failure patients and fPH that were successfully bridged to candidacy and underwent subsequent HTX.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research